chevron_leftBack
As of 6 June 2026, Glycorex Transplantation AB Class B has a market cap of $14.55M USD, ranking #39184 globally and #597 in Sweden.
It ranks #3498 in the Healthcare sector, and #744 in the Medical Devices industry.
Key Stats
Market Cap
$14.55MUSD
136.42M SEK
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4% | 23% | 38% | 19% | -13% | -28% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
GTAB-B
(GTAB.B)
ISIN: SE0000524530
Shares Out.:
Shares Outstanding:
75.586M1
Shares Float:
56.3M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.66 SEK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: GETI-B
|
$5.59B
38K%
52.4B SEK
|
22.2
|
|
|
S
STO: SCIB
|
$4.85B
33K%
45.5B SEK
|
-
|
|
STO: EKTA-B
|
$2.23B
15K%
20.86B SEK
|
-
|
|
STO: VITR
|
$1.59B
11K%
14.87B SEK
|
-
|
|
STO: BONEX
|
$1.53B
10K%
14.32B SEK
|
78.5
|
|
STO: XVIVO
|
$907.38M
6K%
8.5B SEK
|
115.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
1M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
1M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
1M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
869K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
829K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
700K%
|
22.2
|
chevron_leftBack